Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 420,800 shares, a drop of 6.8% from the May 15th total of 451,400 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Ascentage Pharma Group International Stock Performance

OTCMKTS:ASPHF opened at $2.69 on Tuesday. Ascentage Pharma Group International has a 1 year low of $2.35 and a 1 year high of $3.63. The firm has a 50 day moving average of $2.60 and a 200-day moving average of $2.78.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.